Bendamustine reactivates latent Epstein-Barr virus

Click to increase image sizeClick to decrease image size

Acknowledgements

We thank An T. Phan for optimizing the BZLF1 expression assay, Shannon C. Kenney (University of Wisconsin, Madison) for providing the MutuI cell line, and Marielle Cavrois and Marianne L. Gesner at the Gladstone Institutes Flow Cytometry Core for assisting with experiments. This publication was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 TR000004. This publication was made possible with help from the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), an NIH-funded program (P30 AI027763).

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.